[ad_1]
– Now we must give (the Swedish Medicines Agency) MHRA time to carry out its important work and we must await their recommendations, says a spokesman for the British health authority in a comment on the information in the newspaper.
It is already clear that the Pfizer vaccine will be used, as two million Britons will be vaccinated in the next two weeks. According to the newspaper, the Astra Zeneca vaccine will receive the necessary approval within a few days.
Pascal Soriot, CEO of the Swedish-British pharmaceutical giant, says the company and the University of Oxford have now done well with their product, after an initial disappointment when early results showed slightly worse protection than the competitor’s vaccine. .
– We think we have found the winning recipe, he says.
The maternal vaccine, which became the second to be approved in the United States, has yet to be approved in either the UK or the EU.
Astra Zeneca’s vaccine differs from Pfizer-Biontech and Modernas in that it uses a harmless cold virus that delivers the current vaccine with the genetic code of the coronavirus in the body. The others are of the so-called mrna type and introduce a molecule with instructions on how the body itself can make the proteins it wants the immune system to react to.
[ad_2]
